| Code | 3619D | ||||||||||
| MA number | EU/1/95/001/036 | ||||||||||
| Product Form: | sol inj 1x0,24 ml/150 IU (1 napl.skl.pero+4 ihly) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Merck Europe B.V., Netherland | ||||||||||
| Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 20.10.1995 |
| SmPC + PL: |
|
| Safety feature | Yes |
| Data update: | 15.11.2023 |